This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.
The misunderstanding that exists even among usually well informed health officers and physicians in regard to the standardization of biologic products is sufficient reason for a brief consideration of the subject. For example, under the heading "Standardization of Biological Products" on page 1416 of The Journal, May 12, 1917, a note states that the official Conference of State and Territorial Health Officers adopted a resolution recommending that the Public Health Service "establish and promulgate standards as to potency with reference to all biologic products, vaccines and serums, not only with relation to diphtheria and tetanus antitoxin, but especially with relation to antimeningococcus and pneumonia serums, and vaccines for typhoid fever, paratyphoid fever, and bacillary dysentery."
A standard is defined as "that which is set up and established by authority as a rule for the measure of quantity, weight, extent, value or quality; especially the original specimen weight or measure sanctioned
McCOY GW. STANDARDIZATION OF SERUMS AND VACCINES: SOME DIFFICULTIES AND MISUNDERSTANDINGS. JAMA. 1917;LXIX(5):378–381. doi:10.1001/jama.1917.02590320054014
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: